Insulet Corporation AI Adoption Tracker
Last updated: August 9, 2026
Overview
Insulet Corporation is a leader in automated insulin delivery technology, known for its tubeless Omnipod Insulin Management System that has achieved market-leading positions in both type 1 and type 2 diabetes care[1]. The company has demonstrated strong financial performance with 2024 revenue exceeding $2.1 billion, representing 22% year-over-year growth[2]. Insulet's flagship Omnipod 5 Automated Insulin Delivery System integrates with continuous glucose monitors to provide personalized, automated insulin delivery and has become the most-prescribed AID system in the U.S.[3]. The company is leveraging AI across multiple dimensions, including enhancing product algorithms, improving customer experience through predictive analytics, and optimizing internal operations with tools like Microsoft CoPilot and Google Gemini[4].
AI Maturity Index
Radar Comparison
Peer Comparison: Insulet Corporation vs healthcare
Based on 66 companies in sector
| Dimension | Insulet Corporation | Sector Avg | Diff |
|---|---|---|---|
| Adoption | 3.0 | 3.7 | -0.7 |
| Proficiency | 3.0 | 3.5 | -0.5 |
| Impact | 4.0 | 3.6 | +0.4 |
| Overall | 3.4 | 3.6 | -0.2 |
AI Hiring Signals
Insulet Corporation Job Postings Analysis
Tech vs Non-Tech AI Requirements
Non-tech AI adoption exceeds tech roles - strong org-wide AI fluency signal
Top Departments by AI Mention Rate
Analysis
Insulet shows modest AI hiring emphasis with 8.1% of job postings mentioning AI. Interestingly, non-tech roles (8.2%) slightly exceed tech roles (7.7%) in AI expectations, suggesting organization-wide AI integration. This aligns with the company's focus on AI-enhanced customer experience and internal productivity tools.
View Sample Job Postings (8 sources)
Key Metrics
AI Initiatives
Omnipod 5 Algorithm Enhancements with AI
December 2025
FDA-cleared improvements to the Omnipod 5 system featuring enhanced automation and lower glucose target options
New 100 mg/dL Target Glucose setting and improved algorithm to help users stay in Automated Mode with fewer interruptions. Real-world evidence shows improved time in range with no clinically meaningful increase in hypoglycemia.
Discover Data Insights Platform
November 2025
AI-powered data platform using machine learning to deliver actionable insights for diabetes management
Platform analyzes weekly glucose and insulin trends using machine learning algorithms to provide clear, actionable insights for both users and healthcare providers. Currently in limited market release with full launch expected in 2026.
AI-Enhanced Customer Care Operations
October 2025
Deployment of AI foundational models in customer care centers to improve response times and experience
AI implementation at Guadalajara facility showing significant improvements in call and wait times. Also includes AI models for customer retention to intercept patients before behavior changes with diabetes devices.
Internal AI Productivity Tools
October 2025
Organization-wide deployment of AI tools to enhance workforce productivity
Implementation of Microsoft CoPilot and Google Gemini to help software developers reduce documentation time from weeks to days. Focus on skilling up workforce for improved productivity.
Voice Control and Audio AI for Drug Delivery
Q2 2024
Wearable drug delivery device with voice control application and sound chip circuitry
Patent for device that can play audio clips for user assistance and allows hands-free insulin delivery control through voice commands. Includes natural language understanding module for better voice command recognition.
Frequently Asked Questions
Insulet integrates AI into their Omnipod 5 system through enhanced algorithms that automatically adjust insulin delivery based on continuous glucose monitoring data. The system uses machine learning to predict glucose levels and make personalized dosing decisions without user input.
Insulet deploys Microsoft CoPilot and Google Gemini to enhance workforce productivity, particularly helping software developers reduce documentation time from weeks to days and improving overall development efficiency.
The Discover platform uses machine learning to analyze weekly glucose and insulin trends, delivering actionable insights to both patients and healthcare providers. It simplifies data interpretation and helps optimize diabetes therapy management.
AI implementation in Insulet's customer care centers has significantly improved call and wait times. They also use AI models for customer retention to identify and intervene before patients change their diabetes management behavior.
Yes, Insulet has patented technology for voice-controlled drug delivery devices that allow hands-free insulin delivery through voice commands, featuring natural language understanding capabilities for better user interaction.
In Application
| Application | Vendor | Use Case |
|---|---|---|
| Microsoft CoPilot | Microsoft | Software development and documentation automation to reduce development time from weeks to days |
| Google Gemini | Workforce productivity enhancement and internal process optimization | |
| Databricks Data Intelligence Platform | Databricks | Data processing and analytics for manufacturing optimization, customer experience, and regulatory compliance |
| Custom ML Models | Internal | Customer retention and behavior prediction to prevent device abandonment |
| Natural Language Understanding Module | Internal | Voice command recognition for hands-free insulin delivery control |
Sources
Insulet Announces FDA 510(k) Clearance of Omnipod 5 Algorithm Enhancements
Insulet Announces Discover – A Data Insights Platform Coming in 2026
Ashley McEvoy explains how Insulet is using AI to advance diabetes care
Insulet simplifies life for people living with diabetes
Insulet in artificial intelligence: Theme innovation strategy
Insulet Q3 2025 Earnings Report
Insulet Q2 2025 Earnings Report
Insulet Q1 2025 Earnings Report
Related Companies
About AI Tracker
AI Tracker is a research project by Larridin, the AI execution intelligence platform.
Methodology: We analyze earnings calls, press releases, partnership announcements, and product documentation. All assessments are based solely on publicly available information—no private customer data is used.
Maturity Scoring: Each dimension is rated on a 4-tier scale (Nascent → Emerging → Scaling → Leading) based on evidence from public sources. Industry averages are computed as the median across all tracked companies in the sector.